Camp4 Therapeutics reports Q3 results

* Camp4 Therapeutics press release [https://seekingalpha.com/pr/20297823-camp4-reports-third-quarter-2025-financial-results-and-corporate-highlights] (CAMP [https://seekingalpha.com/symbol/CAMP]): Q3 Net loss for the quarter ended September 30, 2025, was $15.1 million compared to $13.5 million for the quarter ended September 30, 2024.
* Cash, cash equivalents, and marketable securities as of September 30, 2025, were $75.3 million, compared to $39.1 million as of June 30, 2025.

MORE ON CAMP4 THERAPEUTICS

* Seeking Alpha’s Quant Rating on Camp4 Therapeutics [https://seekingalpha.com/symbol/CAMP/ratings/quant-ratings]
* Historical earnings data for Camp4 Therapeutics [https://seekingalpha.com/symbol/CAMP/earnings]
* Financial information for Camp4 Therapeutics [https://seekingalpha.com/symbol/CAMP/income-statement]